Case study: no more detectable brain metastases

A case in which brain metastases were no longer detectable. Dr Antonina Rome gives the anamnesis, the role of the targeted drug brigatinib, and how BICOM therapy ran alongside conventional oncology, then argues for standard success criteria so that bioresonance results in cancer care can be compared between practitioners rather than anecdotally.

Practitioner Library Membership Required

You must be a Practitioner Library member to access this content.

Join Now

Already a member? Log in here
author avatar
David Franklin
David Franklin is an advocate of Bioresonance therapy. He has seen how this form of treatment has helped his wife Sarah, who suffers from Addisons disease. David supplies Bicom Optima devices to therapists all over the world, and he also trains them on how to use the medical equipment effectively.
Chat on WhatsAppUsually replies during business hours